Search results for Tenofovir alafenamide

123 hits were found for Tenofovir alafenamide

# Family MCID Name MIFTS Score
1
HMN044 Human Immunodeficiency Virus Type 1 71 0.916
2
c HPT016 Hepatitis B 59 0.903
3
48X005 48,xyyy 39 0.812
4
P HPT021 Hepatitis 67 0.798
5
HMN014 Human Immunodeficiency Virus Infectious Disease 55 0.745
6
IMM167 Immune Deficiency Disease 78 0.633
7
c HPT003 Hepatitis a 62 0.605
8
ACQ007 Acquired Immunodeficiency Syndrome 60 0.545
9
HRP008 Herpes Simiae 25 0.518
10
LVR012 Liver Cirrhosis 62 0.365
11
P LVR013 Liver Disease 68 0.343
12
P FNC004 Fanconi Syndrome 50 0.314
13
P FNC034 Fanconi Renotubular Syndrome 2 40 0.314
14
CHL079 Children's Interstitial Lung Disease 26 0.311
15
c RHB024 Rhabdomyosarcoma 2 67 0.291
16
P HPT023 Hepatocellular Carcinoma 100 0.281
17
P KDN018 Kidney Disease 72 0.266
18
VRL011 Viral Infectious Disease 61 0.257
19
c HPT001 Hepatitis C 62 0.255
20
CMR002 Coumarin Resistance 56 0.252
21
c FBR046 Fibrosis of Extraocular Muscles, Congenital, 1 57 0.250
22
c VRL010 Viral Hepatitis 52 0.226
23
P CRD246 Cardiovascular System Disease 57 0.224
24
P MYC084 Mycobacterium Tuberculosis 1 68 0.216
25
c CHR684 Chronic Kidney Disease 70 0.207
26
c NRD033 Neurodegeneration with Brain Iron Accumulation 2a 69 0.204
27
P BND020 Bone Disease 59 0.203
28
49X006 49, Xxxxy Syndrome 41 0.196
29
ADL002 Adult Syndrome 70 0.194
30
P ART062 Arthrogryposis, Renal Dysfunction, and Cholestasis 1 65 0.189
31
c HPT073 Hepatitis C Virus 72 0.187
32
P OST002 Osteoporosis 74 0.182
33
P BNM029 Bone Mineral Density Quantitative Trait Locus 15 48 0.182
34
c BNM022 Bone Mineral Density Quantitative Trait Locus 8 42 0.182
35
P DRR001 Diarrhea 55 0.182
36
c ACT071 Acute Kidney Failure 60 0.181
37
HYP017 Hypophosphatemia 50 0.181
38
c PRM038 Primary Agammaglobulinemia 44 0.181
39
RCK004 Rickets 68 0.179
40
c INF145 Infantile Liver Failure Syndrome 1 50 0.171
41
CRT084 Creatinine Clearance Quantitative Trait Locus 25 0.162
42
ATX019 Ataxia with Vitamin E Deficiency 42 0.161
43
LPD008 Lipid Metabolism Disorder 62 0.158
44
RPD005 Rapidly Involuting Congenital Hemangioma 38 0.157
45
P PRT133 Proteasome-Associated Autoinflammatory Syndrome 1 81 0.155
46
P LCT001 Lactic Acidosis 51 0.148
47
ANX010 Anxiety 73 0.142
48
NSP002 Nasopharyngitis 43 0.134
49
c BDY007 Body Mass Index Quantitative Trait Locus 1 42 0.132
50
P CNR004 Cone-Rod Dystrophy 2 73 0.125
51
P ABD014 Abdominal Obesity-Metabolic Syndrome 1 64 0.125
52
END086 End Stage Renal Disease 51 0.125
53
DPR016 Depression 63 0.124
54
MNT002 Mental Depression 58 0.124
55
c HYP836 Hypercholesterolemia, Familial, 1 73 0.121
56
LYM143 Lymphoma, Non-Hodgkin, Familial 72 0.121
57
AGN016 Aging 56 0.121
58
ANG049 Angioedema Induced by Ace Inhibitors 40 0.121
59
P LYM118 Lymphoma 68 0.117
60
LYM019 Lymphosarcoma 46 0.117
61
P HYP724 Hyperlipoproteinemia, Type Iii 73 0.116
62
P CRN300 Coronary Heart Disease 1 63 0.116
63
LPP008 Lipoprotein Quantitative Trait Locus 62 0.116
64
P FTT008 Fatty Liver Disease, Nonalcoholic 1 60 0.113
65
CVD001 Covid-19 44 0.113
66
TXC002 Toxic Encephalopathy 53 0.109
67
P LKM071 Leukemia, Chronic Lymphocytic 79 0.100
68
P LKM002 Leukemia 68 0.100
69
NNL005 Non-Alcoholic Fatty Liver Disease 61 0.100
70
DFF005 Diffuse Large B-Cell Lymphoma 55 0.100
71
ART140 Arteries, Anomalies of 52 0.100
72
SHR059 Short Stature, Onychodysplasia, Facial Dysmorphism, and Hypotrichosis 47 0.099
73
ATH013 Atherosclerosis Susceptibility 65 0.095
74
3HY005 3-Hydroxyacyl-Coa Dehydrogenase Deficiency 62 0.095
75
FTT001 Fatty Liver Disease 61 0.095
76
P BCL017 B-Cell Lymphoma 58 0.095
77
RTC005 Reticulosarcoma 47 0.095
78
c SVR001 Severe Acute Respiratory Syndrome 62 0.095
79
P DBT026 Diabetes Mellitus, Noninsulin-Dependent 90 0.090
80
c HPT007 Hepatitis E 53 0.090
81
HYP081 Hypolipoproteinemia 51 0.090
82
CYT018 Cytochrome P450 2d6 Variant 27 0.090
83
PPL061 Papular Epidermal Nevi with Skyline Basal Cell Layers Syndrome 25 0.090
84
P THR014 Thrombocytopenia 67 0.089
85
GRG001 Greig Cephalopolysyndactyly Syndrome 66 0.089
86
HYD058 Hydrops, Lactic Acidosis, and Sideroblastic Anemia 59 0.089
87
NNL006 Non-Alcoholic Steatohepatitis 54 0.089
88
OPT003 Opiate Dependence 50 0.089
89
OPD001 Opioid Abuse 46 0.089
90
GST040 Gastric Adenocarcinoma 70 0.082
91
HYP006 Hypertensive Heart Disease 49 0.082
92
c HYP595 Hypertension, Essential 84 0.080
93
P RNL007 Renal Tubular Acidosis 51 0.080
94
HYP066 Hyperglycemia 61 0.074
95
IRN002 Iron Metabolism Disease 57 0.074
96
c DRR009 Diarrhea 6 46 0.074
97
IMM064 Immunodeficiency, Common Variable, 10 44 0.074
98
SPN362 Spondylometaphyseal Dysplasia, Sedaghatian Type 41 0.074
99
MCL069 Macular Dystrophy, Retinal, 1, North Carolina Type 39 0.074
100
c AMY091 Amyotrophic Lateral Sclerosis 1 89 0.067
101
BRN024 Bronchitis 68 0.067
102
P PLM036 Pulmonary Fibrosis 65 0.067
103
P MTR014 Motor Neuron Disease 65 0.067
104
OST017 Osteomyelitis 64 0.067
105
INT002 Intermittent Claudication 61 0.067
106
P TXP001 Toxoplasmosis 60 0.067
107
ISC004 Ischemia 58 0.067
108
P ALC033 Alcohol Use Disorder 58 0.067
109
P PLM034 Pulmonary Emphysema 55 0.067
110
P ALP008 Alopecia 54 0.067
111
AMY027 Amyotrophic Lateral Sclerosis-Parkinsonism/dementia Complex 1 54 0.067
112
P LTR001 Lateral Sclerosis 54 0.067
113
c PRM092 Primary Lateral Sclerosis, Adult, 1 53 0.067
114
JVN026 Jeavons Syndrome 24 0.067
115
ESP021 Esophageal Cancer 90 0.058
116
MYL069 Myeloma, Multiple 85 0.058
117
P ESP024 Esophagitis 62 0.058
118
P URT039 Urticaria 58 0.058
119
P UVT001 Uveitis 57 0.058
120
P ESP035 Esophagitis, Eosinophilic, 1 57 0.058
121
c INT064 Intermediate Uveitis 55 0.058
122
GYN001 Gynecomastia 49 0.058
123
INF021 Infant Gynecomastia 31 0.058
Content
Loading form....